A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Bristol-Myers Squibb
Pfizer
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Arizona
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Pfizer
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Pfizer
Boehringer Ingelheim
Xencor, Inc.
Calibr, a division of Scripps Research
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Novartis
University Hospital Southampton NHS Foundation Trust
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Nebraska
University of Nebraska
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
Alliance for Clinical Trials in Oncology
Canadian Cancer Trials Group
University of Washington
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
Atara Biotherapeutics
Medical College of Wisconsin
Medical College of Wisconsin
Columbia University
New York Medical College
Roswell Park Cancer Institute
Mayo Clinic
Xencor, Inc.
Medical College of Wisconsin